Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
NVIDIA
NVDA
Vale SA
VALE
KB Home
KBH
US Stock MarketDetailed Quotes
CAPR Capricor Therapeutics
- 15.950
- +0.400+2.57%
Close Feb 14 16:00 ET
- 15.950
- 0.0000.00%
Post 20:01 ET
725.25MMarket Cap-15.64P/E (TTM)
16.225High15.390Low1.96MVolume15.540Open15.550Pre Close30.99MTurnover4.89%Turnover RatioLossP/E (Static)45.47MShares23.40052wk High10.63P/B637.64MFloat Cap3.52052wk Low--Dividend TTM39.98MShs Float7999.998Historical High--Div YieldTTM5.37%Amplitude0.880Historical Low15.843Avg Price1Lot Size
About Capricor Therapeutics Company
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Company Profile
SymbolCAPR
Company NameCapricor Therapeutics
Listing DateMar 9, 2015
Founded1996
CEODr. Linda Marban, PhD
MarketNASDAQ
Employees102
Fiscal Year Ends12-31
Address10865 Road to the Cure,Suite 150
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-727-1755
Websitehttp://www.capricor.com
Company Executives
- Name
- Position
- Salary
- Dr. Linda Marban, PhD
- President, Chief Executive Officer and Director
- 747.32K
- Anthony J. Bergmann, M.B.A.
- Principal Accounting Officer, Chief Financial Officer and Corporate Treasurer
- 730.85K
- Karen G. Krasney, J.D.
- Executive Vice President, General Counsel and Secretary
- 740.77K
- Dr. Frank Litvack,M.D.
- Executive Chairman of the Board
- 759.55K
- George W. Dunbar,Jr
- Independent Director
- 211.13K
- David B. Musket
- Independent Director
- 237.36K
- Dr. Philip J. Gotwals, PhD
- Independent Director
- 467.36K
- Karimah Es Sabar
- Independent Director
- 196.14K
- Earl M. Collier, Jr
- Independent Director
- 222.37K
- Michael Kelliher
- Independent Director
- 681.38K
- Dr. Paul Gisbert Auwaerter, M.B.A.,M.D.
- Independent Director
- 459.43K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.